MAP2K6 and colorectal carcinoma: To further corroborate the importance of MAP2K6 for mediating the effect of miR-625-3p in CRC cells, we generated stable HCT116 cell lines expressing a dominant-negative version of MAP2K6 harbouring a K82A mutation, which abolishes kinase activity16.